TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Mar 7, 4:07 PM ET

Jover Placid 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-05
Jover Placid
See "Remarks"
Transactions
  • Award

    Restricted Share Units

    2025-03-05+56,60356,603 total
    Ordinary Shares (56,603 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4